Publications by authors named "Michiko Imamura"

Claim this Profile
C
Cosmetic outcomes of rotation flap and suture scaffold for breast-conserving therapy in the lower quadrants.
Tomohiko Aihara, Noriko Aritake, Michiko Imamura, Masatsugu Okishiro, Tomoko Higuchi

Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Haruka Kanaoka, Masayuki Nagahashi, Yusa Atake, Akira Hattori, Ayako Bun, Michiko Imamura

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13).
Mayuko Miki, Shintaro Takao, Muneharu Konishi, Yasushi Shigeoka, Masaru Miyashita, Michiko Imamura

Anticancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness and Prospects of Sentinel Lymph Node Biopsy for Patients With Breast Cancer Using the Medical Imaging Projection System.
Yuki Nakamura, Masahiro Takada, Michiko Imamura, Akane Higami, He Jiaxi

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin.
Atsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, Ayako Bun, Hiromi Ozawa, Michiko Imamura

Anticancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Ayako Bun, Yukie Fujimoto, Tomoko Higuchi, Atsushi Sata, Reiko Fukui, Michiko Imamura

Anticancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.
Reiko Fukui, Yukie Fujimoto, Takahiro Watanabe, Natsuko Inoue, Ayako Bun, Michiko Imamura

Anticancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.
Yukie Fujimoto, Natsuko Inoue, Koji Morimoto, Takahiro Watanabe, Seiichi Hirota, Michiko Imamura

Cancer Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Michiko Imamura

Oncotarget· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Yukie Fujimoto, Takahiro Watanabe, Akira I Hida, Tomoko Higuchi, Yoshimasa Miyagawa, Michiko Imamura

Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
Hiromi Ozawa, Atsushi Sata, Reiko Fukui, Ayako Bun, Tomoko Higuchi, Michiko Imamura

Anticancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Tomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, Ayako Bun, Reiko Fukui, Michiko Imamura

Ann Surg Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Yukie Fujimoto, Hiromi Ozawa, Tomoko Higuchi, Yoshimasa Miyagawa, Ayako Bun, Michiko Imamura

Mol Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.
Michiko Imamura, Takashi Morimoto, Chiyomi Egawa, Reiko Fukui, Ayako Bun

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Yoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, Hiromi Ozawa, Yukie Fujimoto, Michiko Imamura

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
Kazuhiro Araki, Yoshinori Ito, Ippei Fukada, Kokoro Kobayashi, Yoshimasa Miyagawa, Michiko Imamura

BMC Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After Mastectomy.
Kazuma Hashimoto, Ayano Tsuji, Shiho Takenaka, Akimune Ohmura, Ryusuke Ueki, Michiko Imamura

Anesth Pain Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
Yukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, Yoshimasa Miyagawa, Ayako Kira, Michiko Imamura

J Surg Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
Takahiro Watanabe, Akira I Hida, Natsuko Inoue, Michiko Imamura, Yukie Fujimoto

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Michiko Imamura, Takashi Morimoto, Takashi Nomura, Shintaro Michishita, Arisa Nishimukai

World J Surg Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai, Yoshimasa Miyagawa, Michiko Imamura

Breast Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of preoperative F-FDG PET/CT for breast cancer subtypes.
Tomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, Yukie Fujimoto, Ayako Yanai, Michiko Imamura

Breast· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
Yukie Enomoto, Takashi Morimoto, Arisa Nishimukai, Tomoko Higuchi, Ayako Yanai, Michiko Imamura

Int J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Michiko Imamura, Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai

Breast Cancer Res Treat· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Ayako Yanai, Natsuko Inoue, Tomoko Yagi, Arisa Nishimukai, Yoshimasa Miyagawa, Michiko Imamura

Clin Breast Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis